This dual-action mechanism is a key distinguishing feature of tirzepatide , setting it apart from other weight-loss and diabetes drugs, like Ozempic or Wegovy, that can target only one of these two hormones and, therefore, only one aspect of metabolic regulation
While all causes and contributors of obesity are not within an individual's control, structured lifestyle modification programs can be effective and feasible to help achieve a 510 % weight reduction and maintain a healthy body weight for many people [[85], [86], [87]]
Probably The role of GLP-1s in preventing and managing cardiometabolic conditions may reduce future health care expenditures by avoiding doctors visits, emergency room care, additional medications, and productivity loss
Reward Pathways: GLP-1 RAs modulate the mesolimbic reward system (including the ventral tegmental area and nucleus accumbens), potentially reducing the hedonic drive to consume palatable foods and even moderating addictive behaviors (Zheng et al., 2024)